查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1840862

機器人切片檢查設備市場按產品類型、技術、應用、最終用戶和手術類型分類－2025-2032年全球預測

Robotic Biopsy Devices Market by Product Type, Technology, Application, End User, Procedure Type - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，機器人切片檢查設備市場規模將成長 11.0661 億美元，複合年成長率為 11.63%。

關鍵市場統計數據
基準年 2024 4.587億美元
預計年份：2025年 5.1117億美元
預測年份 2032 11.661億美元
複合年成長率 (%) 11.63%

本書權威地概述了機器人技術、影像融合和程序創新如何融合，從而改變臨床組織採樣實踐和相關人員的優先事項。

機器人切片檢查解決方案結合了精準的機械結構、先進的影像處理技術和軟體主導的引導，徹底改變了臨床醫生獲取組織樣本的方式，降低了操作差異，提高了診斷的準確性。過去十年間，微創技術與高解析度顯像模式的融合，使機器人平台從小眾研究儀器轉變為滿足日常診斷需求的實用臨床工具。本文概述了該技術的發展現狀，重點介紹了其關鍵的臨床優勢——更高的靶向精度、在特定情況下更短的手術時間以及更低的併發症率——同時也組裝了更廣泛應用該技術所涉及的營運和經濟方面的考慮。

包括醫院系統、診斷中心和門診手術中心在內的相關人員，會從臨床有效性、工作流程整合和投資報酬率等方面評估這些系統。由於機器人切片檢查設備的臨床價值與其引導成像技術密不可分，因此影像相容性和工作流程相容性尤其重要。同時，監管路徑、報銷環境和臨床醫生培訓要求也在不斷發展，以跟上設備創新的步伐。本引言為深入探討技術變革、市場區隔動態、區域差異以及相關人員可用於調整其產品開發、市場推廣和臨床應用策略以適應影像引導組織取樣新情勢的策略槓桿奠定了基礎。

對推動機器人組織採樣技術普及和重新定義競爭優勢的技術、臨床和交付模式轉變進行全面分析。

受技術成熟、臨床需求和醫療服務模式轉變的驅動，機器人切片檢查設備領域正經歷多重變革時期。影像引導和融合技術的進步使得在不同解剖區域進行更精準的標靶操作成為可能，而內建軟體和機器學習則改進了針道規劃並補償了器官運動。這些技術進步與硬體的進步相輔相成。外形規格、模組化架構以及與多種成像系統相容的設備設計，降低了應用門檻，並擴大了其適用的臨床環境範圍。

同時，隨著醫療服務從三級醫院轉移到門診和流動醫療機構，醫療服務模式正變得日益分散化，這需要緊湊且經濟高效的系統。以價值為導向的醫療模式正在獎勵那些能夠透過提高診斷產量比率和減少再次手術來顯著降低後續成本的解決方案。供應鏈和製造趨勢也在轉變，強調彈性採購和本地組裝以應對地緣政治風險。最後，隨著同行評審的切片檢查證據和真實世界經驗檢驗了機器人活體組織切片的風險收益比，臨床接受度正在不斷提高，這加速了臨床醫生、支付方和醫療系統領導者之間關於適用場景和診療路徑的對話。

對關稅主導的成本壓力和供應鏈調整將如何改變2025年機器人切片檢查解決方案的採購、製造選擇和採用時間進行實踐評估

美國關稅政策將於2025年生效，該政策的變化正對研發和銷售機器人切片檢查設備的公司的供應鏈和商業策略產生實際影響。進口關稅若影響關鍵零件（例如精密致動器、影像相容支架和專用光學元件），則直接導致整套系統和耗材的到岸成本增加。因此，製造商和經銷商面臨三種選擇：自行承擔增加的成本、重新分配利潤，或將增加的成本轉嫁給醫療機構買家。

為此，一些戰略調整正變得司空見慣。供應商正在重新評估籌資策略，並探索增加近岸外包和本地組裝，以降低關稅和運輸中斷的風險。與醫院系統和診斷服務提供者的合約條款中擴大包含應對投入成本波動和庫存緩衝的條款。對於規模較小的創新企業而言，不斷上漲的進口成本正在收緊融資，這使得與成熟製造商建立戰略夥伴關係關係和許可協議變得尤為重要，這些協議能夠幫助它們擴大規模並實現採購多元化。最終，關稅主導的成本效率正在減緩一些採購週期，並促使相關人員更加關注整體擁有成本。這表明，在評估新型機器人切片檢查平台時，利害關係人越來越重視臨床表現和採購的靈活性。

詳細的細分分析展示了產品外形規格、影像技術、臨床應用、終端使用者環境和手術類型如何決定臨床適用性和商業化路徑。

細分市場分析表明，產品設計、影像相容性、臨床適應症、終端用戶環境和手術類型決定了機器人切片檢查系統的價值和實現方式。不同的產品類型定義了醫院和診所的特定應用場景。可攜式機器人針對不同手術室之間的靈活性進行了最佳化，並對尋求緊湊型解決方案的門診手術中心極具吸引力。因此，技術選擇決定了工作流程和臨床表現。 CT導引系統可提供更清晰的解剖結構訊息，便於定位深層器官；透視引導平台可實現某些介入手術的即時針頭可視化；MRI引導解決方案在軟組織造影和前列腺定位方面表現出色；超音波引導工具則為床邊介入手術提供經濟高效且無輻射的成像方式。

臨床應用細分突顯了應用場景的多樣性和手術流程的複雜性。乳房切片通常優先考慮速度和患者舒適度；腎臟切片檢查需要在移動的器官中精確控制穿刺深度；肝臟切片檢查需要在穿刺路徑和出血風險之間取得平衡；肺部切片檢查需要在呼吸運動和複雜的胸腔解剖結構中進行導航；前列腺切片檢查受益於MRI融合和更高的靶向精度。終端用戶細分揭示了部署動態。門診手術中心優先考慮便攜性和快速週轉；診斷中心重視吞吐量和與現有影像工作流程的整合；而醫院則需要多功能性、無菌操作流程和全面的服務協議。粗針穿刺切片需要可靠的組織芯採樣機制；細針穿刺活體組織切片需要精細的針頭控制和細胞學方面的專業操作；真空輔助切片檢查需要與抽吸機制和檢體管理系統整合。這種細分觀點指南產品藍圖、臨床檢驗計劃和銷售活動，以確保與實際手術需求保持一致。

從區域觀點分析美洲、歐洲、中東和非洲以及亞太地區的採用促進因素、監管發展和商業化策略。

區域動態影響著機器人切片檢查平台的普及率、監管趨勢和商業化策略。在美國，醫療保健系統對支持早期癌症檢測和微創診斷的創新技術需求強勁，並且已建立報銷機制以加快醫院的採購週期。歐洲、中東和非洲的情況更為複雜，歐盟的監管環境和各國支付方的政策與採購慣例篩檢計畫的增加、私立醫院網路的擴張以及對影像基礎設施的大力投資。然而，成熟市場（擁有高階影像處理設備）和新興市場（成本敏感度和可維護性是影響採購決策的主要因素）之間的普及程度存在差異。

在每個地區，臨床證據的產生、在地服務能力和供應鏈韌性是決定產品持續應用的關鍵因素。區域監管時間表會影響產品上市順序，而針對本地臨床工作流程量身定做的培訓和教育計畫則能加速臨床醫生對產品的接受度。因此，製造商和經銷商優先考慮因地制宜的商業化策略，這些策略反映了支付方獎勵、醫院採購週期以及支援設備長期運作和耗材供應所需的配送網路等方面的差異。

強調夥伴關係、臨床證據、服務模式和智慧財產權優勢的策略競爭動態，將決定機器人切片檢查解決方案的長期領導地位。

機器人切片檢查領域的競爭動態將由影像設備供應商、創新者和能夠提供整合解決方案的臨床相關人員之間的聯盟所塑造。現有影像處理設備製造商利用其客戶關係和平台專業知識提供與機器人相容的模組，而專注於機器人技術的公司則致力於人體工學介面、針頭控制和軟體主導。同時，靈活的新興企業和學術衍生公司正在推出針對特定臨床痛點的創新技術，例如針頭轉向、運動補償和人工智慧輔助的標靶定位，迫使現有企業透過合作、授權或收購來應對。

商業性成功取決於展現臨床價值並實施可擴展的服務模式。那些能夠將可靠的臨床證據與全面的售後支援、耗材供應鏈和培訓服務結合的企業，往往能更快地滲透到醫院系統和診斷網路中。智慧財產權狀況和監管經驗也會構成競爭壁壘，有利於那些擁有成熟合規團隊和臨床試驗能力的企業。最終，競爭格局將獎勵那些能夠將卓越的工程技術與切實可行的商業化策略相結合的企業，從而彌合從前景廣闊的原型產品到能夠無縫整合到日常臨床工作流程和醫療機構採購流程中的設備的鴻溝。

就產品架構、臨床證據產生、供應鏈彈性以及商業模式提供實際的策略建議，以加速產品推廣並保持競爭優勢。

產業領導者應採取多維策略，在技術差異化和商業性可行性之間取得平衡。優先考慮平台模組化，以實現CT引導、透視、MRI引導和超音波引導環境的兼容性，從而拓展應用場景，減少對多種專用機殼的需求。投資開發支援手術規劃、運動校正和決策支援的整合軟體，以提高臨床效用並縮短訓練週期。同時，透過多元化採購、盡可能本地化組裝以及降低關稅和物流波動影響的庫存策略，增強供應鏈韌性。

您的商業策略應強調基於證據的價值溝通。針對高優先級應用（例如切片檢查和前列腺切片檢查）進行有針對性的臨床研究，同時在門診手術和診斷中心等場所建立Proofpoint。提供靈活的購置方案，包括租賃和按需付費模式，以降低門診病人機構的初始資本門檻。與影像設備製造商和醫療系統合作夥伴合作，共同開發檢驗的工作流程，以減少重複手術並提高診斷率。最後，投資擴充性的培訓計畫和遠端支援能力，確保臨床團隊能夠輕鬆採用新技術，這將加速技術應用，並實現這些系統所承諾的流程效率提升。

關鍵見解透過嚴謹的混合方法研究途徑檢驗，該方法結合了專家訪談、監管和臨床文獻研究、專利審查和供應鏈評估。

本調查方法結合了對臨床醫生、採購負責人和技術專家的定性訪談，以及對監管申報文件、臨床文獻和公開設備註冊資訊的系統性二次分析。訪談直接收集了放射科醫生、介入醫生、護理負責人和生物醫學工程團隊關於工作流程整合、臨床醫生偏好和採購限制等方面的見解。基於這些訪談，研究人員提出了關於推廣障礙和價值促進因素的假設，並用二手資料檢驗。二次分析回顧了同行評審的臨床研究、操作指南、法規核准摘要和專利概況，以評估創新軌跡和實行技術的成熟度。

為補充定性分析結果，供應鏈和商業性分析考察了醫院系統和門診病人機構的供應商集中度、組件關鍵性以及採購慣例。此外，還進行了報銷和政策審查，以了解影響醫療經濟效益的支付方獎勵和計費機制。在條件允許的情況下，透過跨資料來源的三角驗證，檢驗了相關趨勢，並為提出的策略建議奠定了堅實的基礎。此方法優先考慮透明度和可重複性，詳細記錄了訪談通訊協定、輔助資訊納入標準以及用於整合臨床、技術和商業性洞察的分析框架。

本文簡要總結了各項結論，重點闡述了機器人切片檢查技術的臨床應用前景、推廣應用的先決條件以及將其普及應用所需的合作行動。

機器人切片檢查設備在診斷流程中扮演日益重要的角色，精準的組織取樣能夠降低不確定性，並改善後續的臨床決策。新興技術，特別是影像融合、軟體主導以及便於工作流程的硬體設計，正與醫療服務模式向微創、門診病人治療方向轉變的趨勢相契合。然而，其更廣泛的應用取決於多種因素的共同作用，包括針對預期用途的可靠臨床證據、與報銷和採購慣例的一致性，以及能夠降低地緣政治和關稅風險的穩健的生產和供應鏈網路。

對於相關人員，協調一致的臨床檢驗投資、與影像和服務供應商建立目標明確的夥伴關係，以及能夠適應不同終端用戶資金限制的靈活商業模式，才是未來的發展方向。當這些要素齊備時，機器人切片檢查平台便能顯著提升診斷效能和病患體驗。隨著技術生態系統的日益成熟，那些兼具嚴謹運作和臨床同理心的機構，有望引領機器人活體組織切片技術從實驗性應用過渡到常規操作。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 機器人切片檢查系統整合了人工智慧驅動的即時成像和針頭引導技術，以提高診斷準確性。
  • 全自動機械臂配備觸覺回饋，可最大限度地減少複雜切片檢查過程中的組織損傷。
  • 設備製造商與遠端醫療平台建立策略夥伴關係，旨在實現全球遠端機器人切片檢查手術。
  • 將超音波、CT 和 MRI 結合的多模態感測器融合技術取得了進展，可用於精確的機器人針頭定位。
  • 門診診所擴大採用機器人切片檢查平台，以減少醫院資源消耗和成本。
  • 開發一種緊湊、攜帶式可攜式切片檢查裝置，用於農村和醫療資源匱乏地區的照護現場應用
  • 人工智慧機器人切片檢查設備獲監管部門核准，加速了新一代微創診斷解決方案的市場准入。
  • 將擴增實境視覺化工具整合到機器人切片檢查系統中，以提高臨床醫生的導航能力和信心
  • 以訂閱模式提供的機器人切片檢查服務日益普及，該服務包含持續維護和軟體升級。
  • 可客製化的一次性切片穿刺針數量增加，這些針筒專為單次使用而設計，旨在提高無菌性並減少交叉感染。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：按產品類型分類的機器人切片檢查設備市場

  • 可攜式機器人
  • 機械臂
  • 桌上型機器人

9. 按技術分類的機器人切片檢查設備市場

  • CT導板
  • 透視指南
  • MRI 指南
  • 超音波引導

第10章 按應用分類的機器人切片檢查設備市場

  • 乳房切片
  • 切片檢查
  • 切片檢查
  • 切片檢查
  • 攝護腺切片檢查

第11章 按最終用戶分類的機器人切片檢查設備市場

  • 門診手術中心
  • 診斷中心
  • 醫院

第12章：依手術類型分類的機器人切片檢查設備市場

  • 核心針穿刺切片
  • 細針穿刺法
  • 真空輔助切片檢查

第13章：各地區機器人切片檢查設備市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 機器人切片檢查設備市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國機器人切片檢查設備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Medtech SA
    • Medrobotics
    • Biobot Surgical Pte Ltd
    • Mazor Robotics
    • iSYS Medizintechnik GmbH
    • Renishaw plc
    • Medtronic
    • Medical Device Business Services, Inc.
    • Stryker
    • Zimmer Biomet
Product Code: MRR-221461476FC5

The Robotic Biopsy Devices Market is projected to grow by USD 1,106.61 million at a CAGR of 11.63% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 458.70 million
Estimated Year [2025] USD 511.17 million
Forecast Year [2032] USD 1,106.61 million
CAGR (%) 11.63%

An authoritative overview of how robotics, imaging integration, and procedural innovation are converging to transform clinical tissue sampling practices and stakeholder priorities

Robotic biopsy solutions are reshaping how clinicians obtain tissue samples, combining precision mechanics, advanced imaging, and software-driven guidance to reduce variability and improve diagnostic confidence. Over the past decade, the convergence of minimally invasive procedural techniques and high-resolution imaging modalities has enabled robotic platforms to transition from niche research instruments to practical clinical tools that address everyday diagnostic needs. This introduction frames the technology landscape by highlighting the core clinical benefits-enhanced targeting accuracy, reduced procedure times in some settings, and potential decreases in complication rates-while acknowledging the operational and economic considerations that accompany broader adoption.

Stakeholders across hospital systems, diagnostic centers, and ambulatory surgical venues are evaluating these systems through the lenses of clinical efficacy, workflow integration, and return on investment. Imaging compatibility and workflow fit are especially critical because the clinical value of a robotic biopsy device is inseparable from the imaging technology that guides it. In parallel, regulatory pathways, reimbursement environments, and clinician training requirements are evolving to keep pace with device innovation. This introduction sets the stage for a deeper exploration of technological shifts, segmentation dynamics, regional variation, and strategic levers that stakeholders can use to align product development, go-to-market, and clinical adoption strategies with the emerging realities of image-guided tissue sampling.

A comprehensive analysis of the technological, clinical, and delivery-model shifts that are driving adoption and redefining competitive advantage in robotic tissue sampling

The landscape for robotic biopsy devices is undergoing several transformative shifts driven by technological maturation, clinical demand, and changing care delivery models. Advances in imaging guidance and fusion capabilities are enabling more accurate targeting across diverse anatomies, while embedded software and machine learning are improving needle path planning and compensating for organ motion. These technical improvements are complemented by hardware evolution: smaller form factors, modular architectures, and instruments designed for compatibility with multiple imaging suites lower barriers to adoption and expand the range of viable clinical settings.

Concurrently, care delivery is decentralizing as procedures migrate from tertiary hospitals into ambulatory and outpatient environments that demand compact, cost-efficient systems. The emphasis on value-based care is incentivizing solutions that demonstrably reduce downstream costs by improving diagnostic yield and reducing repeat procedures. Supply chain and manufacturing trends are also shifting, with an emphasis on resilient sourcing and localized assembly to manage geopolitical risks. Finally, clinical acceptance is strengthening as a growing body of peer-reviewed clinical evidence and real-world experience validates the risk-benefit profile of robotic-assisted biopsies, accelerating dialogues among clinicians, payers, and health system leaders about appropriate use cases and care pathways.

A practical assessment of how tariff-driven cost pressures and supply chain adjustments in 2025 are reshaping procurement, manufacturing choices, and adoption timelines for robotic biopsy solutions

Tariff policy changes in the United States introduced in 2025 have created tangible implications for the supply chains and commercial strategies of companies developing and distributing robotic biopsy devices. When import levies affect key components-precision actuators, imaging-compatible mounts, or proprietary optics-the immediate consequence is an increase in landed cost for finished systems and consumables. Manufacturers and distributors consequently face choices about absorbing incremental costs, reallocating margin, or passing increases to institutional buyers who are themselves under pressure to control procedural expenditures.

In response, several strategic adjustments have become common. Suppliers are reassessing procurement strategies and exploring nearshoring or expanded local assembly to reduce exposure to tariffs and transit disruptions. Contracting practices with hospital systems and diagnostic providers now more frequently include clauses that address input-cost volatility and inventory buffers. For smaller innovators, elevated import costs have tightened runway and increased the importance of strategic partnerships or licensing arrangements with established manufacturers that can offer scale and more diversified sourcing. Ultimately, tariff-driven cost effects slow some purchasing cycles and intensify emphasis on total cost of ownership, which certifies that stakeholder decisions now weigh both clinical performance and procurement resilience in evaluating new robotic biopsy platforms.

In-depth segmentation analysis showing how product form factor, imaging technology, clinical application, end-user environment, and procedure type determine clinical fit and commercialization pathways

Segmentation insights reveal how product design, imaging compatibility, clinical indication, end-user environment, and procedural technique collectively determine where and how robotic biopsy systems deliver value. Differences in product type create distinct hospital and clinic use cases; Portable Robots are optimized for flexibility across procedure rooms and are attractive to ambulatory surgical centers seeking compact solutions, Robotic Arms offer industrial-grade repeatability suited to high-volume hospital suites, and Table Mounted Robots integrate tightly with imaging tables to support precision work in radiology and hybrid operating rooms. Correspondingly, technology choices dictate workflow and clinical performance: CT Guided systems deliver excellent anatomical context for deeper organ targets, Fluoroscopy Guided platforms enable real-time needle visualization for specific interventional procedures, MRI Guided solutions excel in soft-tissue contrast and prostate localization, and Ultrasound Guided tools offer cost-effective, radiation-free imaging for bedside interventions.

Clinical application segmentation highlights the diversity of use cases and procedural complexity. Breast Biopsy procedures often prioritize speed and patient comfort, Kidney Biopsy requires precise depth control in a moving organ, Liver Biopsy balances access paths with bleeding risk, Lung Biopsy demands navigation through respiratory motion and complex thoracic anatomy, and Prostate Biopsy benefits from MRI fusion and enhanced targeting accuracy. End-user segmentation clarifies deployment dynamics: Ambulatory Surgical Centers prioritize portability and rapid turnover, Diagnostic Centers emphasize throughput and integration with existing imaging workflows, and Hospitals require versatility, sterilization pathways, and comprehensive service agreements. Procedure type further influences device design and consumable strategies; Core Needle Biopsy favors robust sampling mechanics for tissue cores, Fine Needle Aspiration demands delicate needle control and cytology-focused handling, and Vacuum Assisted Biopsy necessitates integration with aspirating mechanisms and specimen management systems. Together, these segmentation perspectives guide product roadmaps, clinical validation plans, and sales motions to ensure alignment with real-world procedural needs.

A regional perspective on adoption drivers, regulatory dynamics, and commercialization strategies across the Americas, Europe, Middle East & Africa, and Asia-Pacific

Regional dynamics shape adoption velocity, regulatory trajectories, and commercial strategies for robotic biopsy platforms. In the Americas, health systems exhibit strong demand for innovation that supports early cancer detection and minimally invasive diagnostics, paired with well-established reimbursement frameworks that expedite hospital procurement cycles; the United States remains a focal point for clinical trials, early adopter institutions, and a dense network of imaging and interventional specialists. Europe, Middle East & Africa present a more heterogeneous landscape where regulatory harmonization across the European Union and national payer policies coexist with variable infrastructure and procurement practices in other subregions; this diversity creates opportunities for tiered product offerings and partnerships with regional distributors that can manage local certification and service delivery requirements. Asia-Pacific demonstrates robust demand driven by growing screening programs, expanding private hospital networks, and proactive investments in imaging infrastructure, but adoption nuances differ between mature markets with high-end imaging suites and emerging markets where cost sensitivity and serviceability shape procurement decisions.

Across all regions, clinical evidence generation, localized service capabilities, and supply chain resilience are critical determinants of sustained adoption. Regional regulatory timelines influence product launch sequencing, while training and education programs tailored to local clinical workflows accelerate clinician acceptance. Manufacturers and distributors therefore prioritize region-specific commercialization strategies that reflect differences in payer incentives, hospital procurement cycles, and the distribution networks required to support long-term device uptime and consumable supply.

Strategic competitive dynamics emphasizing partnerships, clinical evidence, service models, and intellectual property advantages that determine long-term leadership in robotic biopsy solutions

Competitive dynamics in the robotic biopsy domain are shaped by alliances between imaging providers, device innovators, and clinical stakeholders that can deliver integrated solutions. Established imaging manufacturers are leveraging their customer relationships and platform expertise to offer robotics-compatible modules, while pure-play robotics firms concentrate on ergonomic interfaces, needle control, and software-driven guidance. At the same time, agile startups and academic spin-offs introduce focused innovations-needle steering, motion compensation, and AI-supported targeting-that address specific clinical pain points and compel incumbents to respond through collaboration, licensing, or acquisition.

Commercial success hinges on the ability to demonstrate clinical value and to implement scalable service models. Organizations that combine robust clinical evidence with comprehensive aftermarket support, consumable supply chains, and training services tend to achieve faster penetration in hospital systems and diagnostic networks. Intellectual property positions and regulatory experience also create barriers that favor players with established compliance teams and clinical trial capabilities. Ultimately, the competitive landscape rewards firms that can align engineering excellence with pragmatic commercialization tactics-crossing the gap from promising prototypes to devices that integrate seamlessly into daily clinical workflows and institutional procurement processes.

Actionable strategic recommendations for product architecture, clinical evidence generation, supply resilience, and commercial models to accelerate adoption and sustain competitive differentiation

Industry leaders should adopt a multi-dimensional strategy that balances technological differentiation with commercial pragmatism. Prioritize platform modularity to enable compatibility across CT Guided, Fluoroscopy Guided, MRI Guided, and Ultrasound Guided environments, which increases addressable use cases and reduces the need for multiple, specialized chassis. Invest in integrated software that supports procedural planning, motion compensation, and decision support to raise clinical utility while shortening training curves. At the same time, strengthen supply chain resilience through diversified sourcing, localized assembly where feasible, and inventory strategies that mitigate tariff and logistics volatility.

Commercial strategies should emphasize evidence-based value communication. Develop targeted clinical studies across prioritized applications-such as Lung Biopsy and Prostate Biopsy-while creating proof points for settings including Ambulatory Surgical Centers and Diagnostic Centers. Offer flexible acquisition options, including leasing and pay-per-use models, to lower initial capital barriers for outpatient facilities. Collaborate with imaging manufacturers and health system partners to co-develop validated workflows that demonstrate reductions in repeat procedures or improved diagnostic yield. Finally, invest in scalable training programs and remote support capabilities so clinical teams can adopt new technologies with confidence, thereby accelerating uptake and realizing the procedural efficiencies these systems promise.

A rigorous mixed-methods research approach combining expert interviews, regulatory and clinical literature review, patent analysis, and supply chain assessment to validate key insights

The research approach combines primary qualitative engagement with clinicians, procurement leaders, and technical experts alongside a systematic secondary review of regulatory filings, clinical literature, and publicly available device registries. Primary interviews provided first-hand perspectives on workflow integration, clinician preferences, and procurement constraints from radiologists, interventionalists, nursing leadership, and biomedical engineering teams. These engagements informed hypotheses about adoption barriers and value drivers that were then tested against secondary evidence. Secondary analysis included a review of peer-reviewed clinical studies, procedural guidelines, regulatory clearance summaries, and patent landscapes to assess innovation trajectories and the maturity of enabling technologies.

Supplementing qualitative insights, supply chain and commercial analyses examined supplier concentration, component criticality, and procurement practices across hospital systems and outpatient facilities. Reimbursement and policy reviews were conducted to understand payer incentives and billing mechanisms that affect procedural economics. Where possible, triangulation across data sources validated trends and provided a robust foundation for the strategic recommendations presented. The methodology prioritizes transparency and reproducibility by documenting interview protocols, inclusion criteria for secondary sources, and analytic frameworks used to synthesize clinical, technical, and commercial findings.

A concise concluding synthesis emphasizing the clinical promise, adoption prerequisites, and coordinated actions required to mainstream robotic biopsy technologies

Robotic biopsy devices are poised to play an increasingly important role in diagnostic pathways where precision tissue sampling reduces uncertainty and improves downstream clinical decision-making. Emerging technical capabilities-particularly in imaging integration, software-driven guidance, and workflow-friendly hardware designs-are aligning with shifts in care delivery that favor minimally invasive, outpatient-friendly interventions. However, broader adoption will depend on a confluence of factors: credible clinical evidence across targeted applications, alignment with reimbursement and procurement practices, and resilient manufacturing and supply networks that mitigate geopolitical and tariff-related risks.

For stakeholders, the path forward involves coordinated investment in clinical validation, purposeful partnerships with imaging and service providers, and flexible commercial models that address the capital constraints of a diverse set of end users. When these elements come together, robotic biopsy platforms can deliver measurable improvements in diagnostic performance and patient experience. As the technology ecosystem matures, organizations that combine operational rigor with clinical empathy will lead the transition from experimental adoption to routine procedural practice.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of AI-driven real-time imaging and needle guidance in robotic biopsy systems for enhanced diagnostic accuracy
  • 5.2. Emergence of fully automated robotic arms with haptic feedback to minimize tissue damage during complex biopsies
  • 5.3. Strategic partnerships between device manufacturers and telemedicine platforms to enable remote robotic biopsy procedures globally
  • 5.4. Advancement in multi-modal sensor fusion technologies combining ultrasound, CT, and MRI for precise robotic needle positioning
  • 5.5. Increasing adoption of robotic biopsy platforms in outpatient clinics to reduce hospital resource utilization and costs
  • 5.6. Development of compact portable robotic biopsy units for point-of-care applications in rural and underserved regions
  • 5.7. Regulatory approvals of AI-enabled robotic biopsy devices accelerating market entry of next-gen minimally invasive diagnostic solutions
  • 5.8. Integration of augmented reality visualization tools within robotic biopsy systems to improve clinician navigation and confidence
  • 5.9. Growth in subscription-based service models offering robotic biopsy as a service with continuous maintenance and software upgrades
  • 5.10. Rise of customizable disposable biopsy needle cartridges designed for single-use to enhance sterility and reduce cross contamination

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Robotic Biopsy Devices Market, by Product Type

  • 8.1. Portable Robots
  • 8.2. Robotic Arms
  • 8.3. Table Mounted Robots

9. Robotic Biopsy Devices Market, by Technology

  • 9.1. CT Guided
  • 9.2. Fluoroscopy Guided
  • 9.3. MRI Guided
  • 9.4. Ultrasound Guided

10. Robotic Biopsy Devices Market, by Application

  • 10.1. Breast Biopsy
  • 10.2. Kidney Biopsy
  • 10.3. Liver Biopsy
  • 10.4. Lung Biopsy
  • 10.5. Prostate Biopsy

11. Robotic Biopsy Devices Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Diagnostic Centers
  • 11.3. Hospitals

12. Robotic Biopsy Devices Market, by Procedure Type

  • 12.1. Core Needle Biopsy
  • 12.2. Fine Needle Aspiration
  • 12.3. Vacuum Assisted Biopsy

13. Robotic Biopsy Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Robotic Biopsy Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Robotic Biopsy Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Medtech SA
    • 16.3.2. Medrobotics
    • 16.3.3. Biobot Surgical Pte Ltd
    • 16.3.4. Mazor Robotics
    • 16.3.5. iSYS Medizintechnik GmbH
    • 16.3.6. Renishaw plc
    • 16.3.7. Medtronic
    • 16.3.8. Medical Device Business Services, Inc.
    • 16.3.9. Stryker
    • 16.3.10. Zimmer Biomet

LIST OF FIGURES

  • FIGURE 1. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. ROBOTIC BIOPSY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. ROBOTIC BIOPSY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ROBOTIC BIOPSY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PORTABLE ROBOTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PORTABLE ROBOTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PORTABLE ROBOTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PORTABLE ROBOTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PORTABLE ROBOTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PORTABLE ROBOTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY ROBOTIC ARMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY ROBOTIC ARMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY ROBOTIC ARMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY ROBOTIC ARMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY ROBOTIC ARMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY ROBOTIC ARMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TABLE MOUNTED ROBOTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TABLE MOUNTED ROBOTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TABLE MOUNTED ROBOTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TABLE MOUNTED ROBOTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TABLE MOUNTED ROBOTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TABLE MOUNTED ROBOTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY CT GUIDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY CT GUIDED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY CT GUIDED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY CT GUIDED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY CT GUIDED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY CT GUIDED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY FLUOROSCOPY GUIDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY FLUOROSCOPY GUIDED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY FLUOROSCOPY GUIDED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY FLUOROSCOPY GUIDED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY FLUOROSCOPY GUIDED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY FLUOROSCOPY GUIDED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY MRI GUIDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY MRI GUIDED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY MRI GUIDED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY MRI GUIDED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY MRI GUIDED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY MRI GUIDED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND GUIDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND GUIDED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND GUIDED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND GUIDED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND GUIDED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND GUIDED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY BREAST BIOPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY BREAST BIOPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY BREAST BIOPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY BREAST BIOPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY BREAST BIOPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY BREAST BIOPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY KIDNEY BIOPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY KIDNEY BIOPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY KIDNEY BIOPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY KIDNEY BIOPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY KIDNEY BIOPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY KIDNEY BIOPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY LIVER BIOPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY LIVER BIOPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY LIVER BIOPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY LIVER BIOPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY LIVER BIOPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY LIVER BIOPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY LUNG BIOPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY LUNG BIOPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY LUNG BIOPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY LUNG BIOPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY LUNG BIOPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY LUNG BIOPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROSTATE BIOPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROSTATE BIOPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROSTATE BIOPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROSTATE BIOPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROSTATE BIOPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROSTATE BIOPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY CORE NEEDLE BIOPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY CORE NEEDLE BIOPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY CORE NEEDLE BIOPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY CORE NEEDLE BIOPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY CORE NEEDLE BIOPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY CORE NEEDLE BIOPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY FINE NEEDLE ASPIRATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY FINE NEEDLE ASPIRATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY FINE NEEDLE ASPIRATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY FINE NEEDLE ASPIRATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY FINE NEEDLE ASPIRATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY FINE NEEDLE ASPIRATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY VACUUM ASSISTED BIOPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY VACUUM ASSISTED BIOPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY VACUUM ASSISTED BIOPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY VACUUM ASSISTED BIOPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY VACUUM ASSISTED BIOPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY VACUUM ASSISTED BIOPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. AMERICAS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 126. AMERICAS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 127. AMERICAS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 128. AMERICAS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 129. AMERICAS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 130. AMERICAS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 131. AMERICAS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 132. AMERICAS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 133. AMERICAS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 134. AMERICAS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 135. AMERICAS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 136. AMERICAS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. NORTH AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 140. NORTH AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 142. NORTH AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 144. NORTH AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 146. NORTH AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 148. NORTH AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. LATIN AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 152. LATIN AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 154. LATIN AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 156. LATIN AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 158. LATIN AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 160. LATIN AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 173. EUROPE ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. EUROPE ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. EUROPE ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. EUROPE ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 177. EUROPE ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 178. EUROPE ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 179. EUROPE ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 180. EUROPE ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 181. EUROPE ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. MIDDLE EAST ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. MIDDLE EAST ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 190. MIDDLE EAST ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 192. MIDDLE EAST ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 194. MIDDLE EAST ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 195. MIDDLE EAST ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 196. MIDDLE EAST ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 197. AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 200. AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 201. AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 202. AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 203. AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 204. AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 205. AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 206. AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 207. AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. ASIA-PACIFIC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 213. ASIA-PACIFIC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 215. ASIA-PACIFIC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 216. ASIA-PACIFIC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 217. ASIA-PACIFIC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 218. ASIA-PACIFIC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 219. ASIA-PACIFIC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 220. ASIA-PACIFIC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. ASEAN ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. ASEAN ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. ASEAN ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. ASEAN ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 227. ASEAN ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 228. ASEAN ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 229. ASEAN ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 230. ASEAN ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 231. ASEAN ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 232. ASEAN ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 233. ASEAN ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. ASEAN ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 235. GCC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. GCC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. GCC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. GCC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 239. GCC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 240. GCC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 241. GCC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 242. GCC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 243. GCC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. GCC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 245. GCC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 246. GCC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPEAN UNION ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPEAN UNION ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPEAN UNION ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPEAN UNION ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPEAN UNION ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPEAN UNION ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPEAN UNION ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPEAN UNION ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPEAN UNION ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPEAN UNION ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 259. BRICS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. BRICS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. BRICS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. BRICS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 263. BRICS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 264. BRICS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 265. BRICS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. BRICS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 267. BRICS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 268. BRICS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 269. BRICS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 270. BRICS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 271. G7 ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. G7 ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. G7 ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. G7 ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 275. G7 ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 276. G7 ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 277. G7 ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 278. G7 ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 279. G7 ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. G7 ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 281. G7 ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. G7 ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 283. NATO ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 284. NATO ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 285. NATO ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. NATO ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 287. NATO ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 288. NATO ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 289. NATO ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 290. NATO ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 291. NATO ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 292. NATO ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 293. NATO ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. NATO ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 295. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 296. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 297. UNITED STATES ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 298. UNITED STATES ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 299. UNITED STATES ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 300. UNITED STATES ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 301. UNITED STATES ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 302. UNITED STATES ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 303. UNITED STATES ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 304. UNITED STATES ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 305. UNITED STATES ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 306. UNITED STATES ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 307. CANADA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 308. CANADA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 309. CANADA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 310. CANADA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 311. CANADA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 312. CANADA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 313. CANADA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 314. CANADA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 315. CANADA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. CANADA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 317. MEXICO ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 318. MEXICO ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 319. MEXICO ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 320. MEXICO ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 321. MEXICO ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 322. MEXICO ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 323. MEXICO ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 324. MEXICO ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 325. MEXICO ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 326. MEXICO ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 327. BRAZIL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 328. BRAZIL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY P